featured
A Dose-Dense Short-Term Therapy for HIV/AIDS Patients With High-Risk Burkitt Lymphoma or High-Grade B-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Dose-Dense Short-Term Therapy for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients With High-Risk Burkitt Lymphoma or High-Grade B-Cell Lymphoma: Safety and Efficacy Results of the "CARMEN" Phase II Trial
Br. J. Haematol 2020 Oct 21;[EPub Ahead of Print], AJM Ferreri, C Cattaneo, A Lleshi, L Verga, B Allione, F Facchetti, M Ponzoni, M Foppoli, D Ferrari, L Rigacci, L Pecciarini, G Donadoni, L Fumagalli, M Sassone, T Calimeri, G Rossi, M Spina, A ReFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.